2 resultaten
Goedgekeurd WMOWerving gestopt
Primary* To evaluate whether the efficacy of nilotinib is superior to the control arm (as measured by progression free survivalSecondary* To compare the response rate, and time to response, duration of response, and time to tumor progression of…
Goedgekeurd WMOWerving nog niet gestart
De interactie van caffeine en dipyridamole bij ischemie-reperfusie schade onderzoeken.